Tirzepatide & Triple Agonist Research Compounds in Ireland

Available GLP-1 Research Compounds — Ireland

Irish Peptide Research supplies Tirzepatide and Triple Agonist (GLP-1/GIP/Glucagon) as research compounds in Ireland. All products are for laboratory and in vitro research use only, dispatched from Co. Galway.

Tirzepatide — Ireland

Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for its combined incretin signalling profile. Available in 10mg, 15mg, and 20mg vials for research use.

Triple Agonist (GLP-1/GIP/Glucagon) — Ireland

A triple GLP-1/GIP/glucagon receptor agonist — one of the most advanced multi-pathway metabolic research compounds available. Also referred to as Retatrutide in the research literature. Available in 10mg, 15mg, and 20mg vials.

Also available: BPC-157, TB-500, and GHK-Cu peptide research compounds in Ireland.